Indonesia Malaysia Vietnam Thailand Philippines Australia New Zealand China Korea And India Veterinary Medicine Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 6,811.52 |
 CAGR |
% |
| Major Markets Players |
>印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场，按产品（疫苗、药物和补充剂）、动物类型（食品生产和伴侣动物）、剂量（固体、液体和半固体）、给药途径（口服、肠外和外用）、应用（口蹄疫、自身免疫性疾病、细菌性疾病、蠕虫感染、蓝舌病、犬特应性皮炎等）、最终用户（医院、兽医诊所、家庭护理环境和实验室）、分销渠道（直接招标、零售销售、网上药店等） - 行业趋势和预测到 2030 年。
印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场分析及规模
印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场本质上是分散的，因为它由许多全球参与者组成，例如 Zoetis Services LLC、Boehringer Ingelheim International GmbH.、Virbac、Ceva 和 Dechra Pharmaceuticals PLC. 等。这些公司的存在为整个地区的兽药提供了具有竞争力的价格。由于这些参与者在区域和国际层面的存在，供应商和制造商提供具有不同规格和特点的产品，适合所有预算。宠物拥有量的增加和宠物的人性化正在推动市场增长。此外，动物疾病患病率的上升预计将推动市场增长。
Data Bridge Market Research 分析称，预计到 2030 年，印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度的兽医用药市场价值将达到 68.1152 亿美元，预测期内复合年增长率为 10.1%。本市场报告还深入介绍了定价分析和技术进步。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 - 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
产品（疫苗、药物和补充剂）、动物类型（食品生产和伴侣动物）、剂量（固体、液体和半固体）、给药途径（口服、肠外和外用）、应用（口蹄疫、自身免疫性疾病、细菌性疾病、蠕虫感染、蓝舌病、犬特应性皮炎等）、最终用户（医院、兽医诊所、家庭护理机构和实验室）、分销渠道（直接招标、零售、网上药店等） |
|
覆盖国家 |
印度、澳大利亚、中国、印度尼西亚、马来西亚、新西兰、韩国、越南、泰国和菲律宾 |
|
涵盖的市场参与者 |
Zoetis Services LLC（美国）、Boehringer Ingelheim International GmbH.（德国）、Virbac（法国）、Ceva（法国）、Dechra Pharmaceuticals PLC（英国）、HUVEPHARMA（保加利亚）、Phibro Animal Health Corporation（美国）、Kemin Industries, Inc.（美国）、Vetoquinol（法国）、Mankind Pharma（印度）、Indian Immunologicals Ltd.（印度）、ECO Animal Health Ltd（英国）、Biologische Heilmittel Heel GmbH、Alivira Animal Health Limited、Jurox Pty Limited、Biogénesis Bagó（德国）、Bentoli（美国）、Inovet（匈牙利）、MSD Animal Health（美国）、Zovix Pharmaceuticals（印度）和Valor Chemical Co., Ltd（中国）等 |
市场定义
兽药市场是指开发、生产和销售动物药品和其他保健产品的行业。这包括宠物、牲畜和其他动物的药品。市场的发展受到对动物保健服务和产品日益增长的需求以及对动物健康和福利重要性的日益认识的推动。兽药市场包括疫苗、抗生素、杀虫剂和消炎药等各种产品。市场还受到政府法规、技术进步和竞争水平等因素的影响。
印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
司机
增加宠物拥有量和宠物人性化
世界上许多文化中都有养宠物的习惯。在印度、中国、韩国、泰国、越南和澳大利亚等许多国家，大多数人都养宠物。由于对陪伴的渴望、健康益处、对宠物态度的转变以及可支配收入的增加等多种因素，养宠物的人数正在增加。宠物提供陪伴和情感支持，这对于独居或社交活动有限的人来说尤其重要。研究表明，养宠物可以带来许多健康益处，包括降低血压、减轻压力和改善心理健康。因此，越来越多的人搬到城市地区，他们可能会感到孤立和与大自然脱节。养宠物可以提供一种与自然世界的联系感和一种安慰的源泉。
同样，随着可支配收入的增加，人们可能会有更多的钱花在宠物和与宠物相关的费用上，如食物、玩具和医疗保健。随着时间的推移，人们对宠物的态度发生了变化，现在许多人将宠物视为家庭成员，而不仅仅是动物。社交媒体的兴起也促进了养宠物的流行，许多人在网上分享宠物的照片和故事，并与其他宠物主人联系。同样，宠物的人性化是指将宠物视为家庭成员并为它们提供与人类家庭成员相同程度的照顾和关注的趋势。这包括提供高质量的食物、医疗保健和美容服务，并将宠物视为伴侣和情感支持的来源。
因此，随着越来越多的人收养宠物，对兽药的总体需求也随之增加，以满足这些宠物的需求。宠物主人对宠物的预防性医疗保健越来越感兴趣，其中包括定期检查和接种疫苗。这导致对疫苗、跳蚤和蜱虫预防剂等兽药的需求增加。总体而言，由于宠物主人寻求为宠物提供最好的护理和治疗，因此收养宠物会导致对兽药的需求增加。随着宠物拥有量的不断增长以及宠物主人对宠物健康和福祉的投入越来越多，预计这一趋势将继续下去。
动物疾病日益流行
动物疾病的增多与兽药的增多有关，因为随着动物疾病数量的增加，对有效治疗和预防措施的需求也随之增加。这导致开发和生产更多的兽药来治疗影响动物的各种疾病和状况。
兽药的使用对于管理和控制动物疾病至关重要，其有效性有助于减少疾病的传播并改善动物健康。因此，对兽药的需求不断增加与动物疾病数量的增加以及对有效干预措施进行管理的需求直接相关。
例如，
- 2022 年 12 月，根据 NCBI 的数据，马来西亚爆发了 2021 年高致病性禽流感 (HPAI)，这是一种影响鸟类的病毒性疾病。此次疫情导致数千只鸟被扑杀，给该国的家禽业造成了重大损失
- 2021 年 9 月，施普林格·自然杂志发表文章称，2019 年，中国爆发了非洲猪瘟 (ASF)，这是一种影响猪的高度传染性疾病。疫情导致数百万头猪被扑杀，给该国的猪肉行业造成了重大损失
根据上述情况，可以得出结论，动物疾病的日益流行正在推动预测期内印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽医药市场的增长。
机会
新型个性化兽药的开发
新型个性化兽药的开发为兽药市场带来了重大机遇。个性化兽药是指根据特定动物的基因构成、病史和其他因素使用靶向疗法。这种方法可以实现更精确、更有效的治疗，副作用更少。个性化兽药的开发与基因组学和其他生物医学研究领域的进步密切相关。这些进步使研究人员能够更好地了解动物疾病的根本原因，并开发针对这些原因的靶向疗法。此外，宠物主人和兽医对个性化兽药的需求日益增长。
这种需求推动了兽药市场的创新，新产品和疗法正在开发中，以解决各种疾病。此外，个性化兽药的开发也推动了动物诊断市场的增长。随着越来越多的动物被诊断出患有特定疾病或病症，对能够准确识别这些病症的诊断测试的需求也日益增加。总体而言，新型个性化兽药的开发为兽药市场的增长创造了巨大的机会。随着研发的不断推进，我们可以期待看到这一重要领域的持续创新和增长。
克制/挑战
兽药价格昂贵
兽药价格过高可能会限制宠物主人和农民的负担能力，从而导致对这些药物的需求减少。这可能会导致兽药制造商和分销商的收入减少。当宠物主人或农民无法负担高昂的兽药费用时，他们可能不会遵守推荐的治疗方案。这可能会导致动物健康状况不佳并降低药物的有效性。
兽药价格高可能会吸引新进入者进入市场，提供低价替代品。这可能会增加竞争并减少现有制造商的市场份额。兽药价格高可能会引起监管机构的审查，并导致市场监管力度加大。这可能会增加制造商和分销商的成本，导致消费者支付更高的价格。总体而言，兽药价格高可能会通过减少需求、增加竞争和引起监管机构的关注来限制市场的增长。
新冠肺炎疫情对印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场的影响
COVID-19 对印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场产生了负面影响。封锁限制导致各种挑战的出现，例如交通和通讯设施减少以及兽医医院就诊次数减少，从而延迟了治疗程序。
COVID-19 疫情在一定程度上对市场产生了负面影响。然而，政府的支持不断增加以及兽药和技术的进步预计将为市场增长提供丰厚的机会。此外，市场参与者之间日益增多的伙伴关系、收购和合作预计将进一步推动市场增长。此外，自 COVID-19 疫情后市场开放以来，增长率一直很高，预计该行业将有相当大的增长。市场参与者正在开展多项活动来改进兽药。通过这种方式，公司将为市场带来进步和创新。
最新动态
- 2023 年 4 月，默沙东动物保健公司获得欧盟委员会对牛用 BOVILIS Nasalgen-C 活疫苗的上市许可。这有助于该公司在全球市场上确立地位。
- 2022 年 9 月，Zoetis Services LLC 宣布已完成对 Jurox 的收购，Jurox 是一家私营动物保健公司，开发、制造和销售用于治疗牲畜和伴侣动物的各种兽药。
印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场范围
印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度的兽药市场根据产品、动物类型、剂量、给药途径、应用、最终用户和分销渠道分为七个显著的细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
产品
- 疫苗
- 药物
- 补充剂
根据产品，市场分为疫苗、药物和补充剂。
动物类型
- 食品生产
- 伴侣动物
根据动物类型，市场分为食品生产和伴侣动物。
剂量
- 坚硬的
- 液体
- 半固体
根据剂量，市场分为固体、液体和半固体。
给药途径
- 口服
- 肠外
- 主题
根据给药途径，市场分为口服、肠外和外用。
应用
- 口蹄疫
- 自身免疫性疾病
- 细菌性疾病
- 蠕虫感染
- 蓝舌病
- 犬特应性皮炎
- 其他的
根据应用，市场分为口蹄疫、自身免疫性疾病、细菌性疾病、蠕虫感染、蓝舌病、犬特应性皮炎等。
最终用户
- 医院
- 兽医诊所
- 家庭护理设置
- 实验室
根据最终用户，市场分为医院、兽医诊所、家庭护理机构和实验室。
分销渠道
- 直接招标
- 零售销售
- 网上药店
- 其他的
根据分销渠道，市场分为直接招标、零售、网上药店和其他。
印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场分析/洞察
分析了印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场，并按国家、产品、动物类型、剂量、给药途径、应用、最终用户和分销渠道提供了市场规模洞察和趋势，如上所述。本市场报告涵盖的国家包括印度、澳大利亚、中国、印度尼西亚、马来西亚、新西兰、韩国、越南、泰国和菲律宾。印度以最大的市场份额主导市场。这一份额归因于 Zoetis Services LLC、Boehringer Ingelheim International GmbH.、Virbac、Ceva 和 Dechra Pharmaceuticals PLC. 等主要市场参与者的存在。预计在预测期内，宠物拥有量和宠物人性化的增加将推动该地区市场的增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势、波特五力分析和案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响以及贸易路线。
竞争格局和印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场份额分析
印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
在印度尼西亚、马来西亚、越南、泰国、菲律宾、澳大利亚、新西兰、中国、韩国和印度兽药市场运营的一些主要市场参与者包括 Zoetis Services LLC（美国）、Boehringer Ingelheim International GmbH.（德国）、Virbac（法国）、Ceva（法国）、Dechra Pharmaceuticals PLC（英国）、HUVEPHARMA（保加利亚）、Phibro Animal Health Corporation（美国）、Kemin Industries, Inc.（美国）、Vetoquinol（法国）、Mankind Pharma（印度）、Indian Immunologicals Ltd.（印度）、ECO Animal Health Ltd（英国）、Biologische Heilmittel Heel GmbH、Alivira Animal Health Limited、Jurox Pty Limited、Biogénesis Bagó（德国）、Bentoli（美国）、Inovet（匈牙利）、MSD Animal Health（美国）、Zovix Pharmaceuticals（印度）和Valor Chemical Co., Ltd（中国）等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 CURRENCY AND PRICING
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
5 INDUSTRY INSIGHTS
5.1 PATENT ANALYSIS
5.2 DRUG TREATMENT RATE BY MATURED MARKETS
5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
5.4 PATIENT FLOW DIAGRAM
5.5 KEY PRICING STRATEGIES
5.6 KEY PATIENT ENROLLMENT STRATEGIES
6 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PET OWNERSHIP AND HUMANIZATION OF PETS
7.1.2 GROWING PREVALENCE OF ANIMAL DISEASES
7.1.3 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY
7.1.4 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE
7.2 RESTRAINTS
7.2.1 HIGH COST OF VETERINARY MEDICINES
7.2.2 STRINGENT REGULATORY REQUIREMENTS FOR APPROVAL
7.3 OPPORTUNITIES
7.3.1 DEVELOPMENT OF NOVEL AND PERSONALIZED VETERINARY MEDICINES
7.3.2 INCREASING TREND TOWARDS PREVENTIVE HEALTHCARE FOR ANIMALS
7.3.3 RISING DEMAND FOR NATURAL AND HERBAL VETERINARY MEDICINES
7.4 CHALLENGES
7.4.1 LIMITED R&D FUNDING FOR VETERINARY MEDICINES
7.4.2 LACK OF SKILLED VETERINARY PROFESSIONALS
8 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 VACCINES
8.2.1 LIVE ATTENUATED VACCINES
8.2.2 TOXOID VACCINES
8.2.3 RECOMBINANT VACCINES
8.2.4 INACTIVATED VACCINES
8.2.5 OTHERS
8.3 MEDICATION
8.3.1 ANTIBIOTICS
8.3.1.1 AMOXICILLIN
8.3.1.2 AMPICILLIN
8.3.1.3 LINCOMYCIN
8.3.1.4 COLISTIN
8.3.1.5 GENTAMICIN
8.3.1.6 TETRACYCLINE
8.3.1.7 DOXYCYCLINE
8.3.1.8 TYLOSIN
8.3.1.9 OTHERS
8.3.2 ANALGESICS
8.3.2.1 ANTI-INFLAMMATORY (NSAIDS)
8.3.2.2 ACETAMINOPHEN
8.3.2.3 FIROCOXIB
8.3.2.4 MELOXICAM
8.3.2.5 CARPROFEN
8.3.2.6 DERACOXIB
8.3.2.7 PHENYLBUTAZONE
8.3.2.8 OTHERS
8.3.2.9 OPIOIDS
8.3.2.10 MU AGONISTS
8.3.2.10.1 MORPHINE
8.3.2.10.2 OXYMORPHONE
8.3.2.10.3 METHADONE
8.3.2.10.4 MEPERIDINE
8.3.2.10.5 OTHERS
8.3.2.11 KAPPA AGONIST-MU ANTAGONIST
8.3.2.11.1 BUTORPHANOL
8.3.2.11.2 OTHERS
8.3.2.12 PARTIAL MU AGONIST
8.3.2.13 BUPRENORPHINE
8.3.2.14 OTHERS
8.3.3 PARASITICIDES
8.3.3.1 AMPROLIUM
8.3.3.2 BENZIMIDAZOLES
8.3.3.3 NITROIMIDAZOLES
8.3.3.4 ALBENDAZOLE
8.3.3.5 PIPERAZINE
8.3.3.6 DELTAMETHRIN
8.3.3.7 LEVAMISOLE
8.3.3.8 OTHERS
8.3.4 ANTIHISTAMINES
8.3.4.1 CETIRIZINE
8.3.4.2 BROMPHENIRAMINE
8.3.4.3 DIPHENHYDRAMINE
8.3.4.4 TERFENADINE
8.3.4.5 TRIMEPRAZINE
8.3.4.6 OTHERS
8.3.5 CORTICOSTEROIDS
8.3.5.1 PREDNISONE
8.3.5.2 PREDNISOLONE
8.3.5.3 DEXAMETHASON
8.3.5.4 OTHERS
8.3.6 ANTIBLOAT
8.3.6.1 DOCUSATE
8.3.6.2 SIMETHICONE
8.3.6.3 OTHERS
8.3.7 HORMONAL
8.3.7.1 EQUINE CHORIONIC GONADOTROPIN
8.3.7.2 CLOPROSTENOL
8.3.7.3 OXYTOCIN
8.3.7.4 OTHERS
8.4 SUPPLEMENTS
8.4.1 VITAMINS
8.4.2 MINERALS
8.4.3 MOLD INHIBITOR
8.4.4 TOXIN BINDER
8.4.5 FEED ACIDIFIERS
8.4.6 OTHERS
9 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE
9.1 OVERVIEW
9.2 FOOD PRODUCTION
9.2.1 POULTRY
9.2.2 CATTLE
9.2.3 SWINE
9.2.4 FISH
9.2.5 OTHERS
9.3 COMPANION ANIMALS
9.3.1 DOGS
9.3.2 CATS
9.3.3 HORSES
9.3.4 OTHERS
10 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY DOSAGE
10.1 OVERVIEW
10.2 SOLID
10.2.1 TABLET
10.2.2 POWDER
10.2.3 OTHERS
10.3 LIQUID
10.3.1 SYRUP
10.3.2 SUSPENSION
10.3.3 SOLUTION
10.3.4 BOLUS
10.3.5 OTHERS
10.4 SEMI-SOLID
10.4.1 GEL
10.4.2 CREAM
10.4.3 OTHERS
11 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION
11.1 OVERVIEW
11.2 ORAL
11.3 PARENTERAL
11.4 TOPICAL
12 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 FOOT AND MOUTH DISEASE
12.3 AUTOIMMUNE DISEASES
12.4 BACTERIAL DISEASES
12.5 HELMINTHES INFECTION
12.6 BLUETONGUE
12.7 CANINE ATOPIC DERMATITIS
12.8 OTHERS
13 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA & INDIA VETERINARY MEDICINE MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 VETERINARY CLINICS
13.4 HOMECARE SETTINGS
13.5 LABORATORIES
14 INDONESIA, MALAYSIA, VIETNAM,THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, & INDIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAIL SALES
14.4 ONLINE PHARMACY
14.5 OTHERS
15 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: INDIA
15.2 COMPANY SHARE ANALYSIS: AUSTRALIA
15.3 COMPANY SHARE ANALYSIS: CHINA
15.4 COMPANY SHARE ANALYSIS: INDONESIA
15.5 COMPANY SHARE ANALYSIS: MALAYSIA
15.6 COMPANY SHARE ANALYSIS: NEW ZEALAND
15.7 COMPANY SHARE ANALYSIS: KOREA
15.8 COMPANY SHARE ANALYSIS: VIETNAM
15.9 COMPANY SHARE ANALYSIS: THAILAND
15.1 COMPANY SHARE ANALYSIS: PHILIPPINES
16 COMPANY PROFILE
16.1 ZOETIS SERVICES LLC
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENTS
16.2 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 VIRBAC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENT
16.4 CEVA
16.4.1 COMPANY SNAPSHOT
16.4.2 PRODUCT PORTFOLIO
16.4.3 RECENT DEVELOPMENTS
16.5 DECHRA PHARMACEUTICALS PLC
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 ALIVIRA ANIMAL HEALTH LIMITED
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 BENTOLI
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
16.8 BIOGÉNESIS BAGÓ
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 BIOLOGISCHE HEILMITTEL HEEL GMBH
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 ECO ANIMAL HEALTH LTD
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 HUVEPHARMA
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 INDIAN IMMUNOLOGICALS LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 INOVET
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 JUROX PTY LIMITED.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 KEMIN INDUSTRIES, INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENT
16.16 MANKIND PHARMA
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT PORTFOLIO
16.16.4 RECENT DEVELOPMENT
16.17 MSD ANIMAL HEALTH
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 PHIBRO ANIMAL HEALTH CORPORATION.
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 VALOR CHEMICAL CO., LTD
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENT
16.2 VETOQUINOL
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 ZOVIX PHARMACEUTICALS.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 INDIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 2 AUSTRALIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 3 CHINA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 INDONESIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 5 MALAYSIA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 6 NEW ZEALAND VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 7 KOREA VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 8 VIETNAM VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 9 THAILAND VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 PHILIPPINES VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 11 INDIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 12 AUSTRALIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 13 CHINA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 14 INDONESIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 15 MALAYSIA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 16 NEW ZEALAND VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 17 KOREA VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 18 VIETNAM VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 19 THAILAND VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 20 PHILIPPINES VACCINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 21 INDIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 22 AUSTRALIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 23 CHINA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 24 INDONESIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 25 MALAYSIA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 26 NEW ZEALAND MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 27 KOREA MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 28 VIETNAM MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 29 THAILAND MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 30 PHILIPPINES MEDICATIONS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 31 INDIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 32 AUSTRALIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 33 CHINA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 34 INDONESIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 35 MALAYSIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 36 NEW ZEALAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 37 KOREA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 38 VIETNAM ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 39 THAILAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 40 PHILIPPINES ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 41 INDIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 42 AUSTRALIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 43 CHINA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 44 INDONESIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 45 MALAYSIA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 46 NEW ZEALAND ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 47 KOREA ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 48 VIETNAM ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 49 THAILAND ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 50 PHILIPPINES ANALGESICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 51 INDIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 52 AUSTRALIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 53 CHINA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 54 INDONESIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 55 MALAYSIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 56 NEW ZEALAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 57 KOREA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 58 VIETNAM ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 59 THAILAND ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 60 PHILIPPINES ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 61 INDIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 AUSTRALIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 63 CHINA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 64 INDONESIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 65 MALAYSIA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 66 NEW ZEALAND OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 67 KOREA OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 68 VIETNAM OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 69 THAILAND OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 70 PHILIPPINES OPIOIDS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 71 INDIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 72 AUSTRALIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 73 CHINA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 74 INDONESIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 75 MALAYSIA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 76 NEW ZEALAND MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 77 KOREA MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 78 VIETNAM MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 79 THAILAND MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 80 PHILIPPINES MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 81 INDIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 82 AUSTRALIA KAPPA AGONIST-MU ANTAGONIST S IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 CHINA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 84 INDONESIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 85 MALAYSIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 86 NEW ZEALAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 87 KOREA KAPPA AGONIST-MU ANTAGONIST S IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 88 VIETNAM KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 89 THAILAND KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 90 PHILIPPINES KAPPA AGONIST-MU ANTAGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 91 INDIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 92 AUSTRALIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 CHINA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 94 INDONESIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 95 MALAYSIA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 NEW ZEALAND PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 97 KOREA PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 98 VIETNAM PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 99 THAILAND PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 100 PHILIPPINES PARTIAL MU AGONIST IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 101 INDIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 102 AUSTRALIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 103 CHINA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 104 INDONESIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 105 MALAYSIA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 106 NEW ZEALAND PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 107 KOREA PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 108 VIETNAM PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 109 THAILAND PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 110 PHILIPPINES PARASITICIDES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 111 INDIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 112 AUSTRALIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 113 CHINA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 114 INDONESIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 115 MALAYSIA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 116 NEW ZEALAND ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 117 KOREA ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 118 VIETNAM ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 119 THAILAND ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 120 PHILIPPINES ANTIHISTAMINES IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 121 INDIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 122 AUSTRALIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 123 CHINA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 124 INDONESIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 125 MALAYSIA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 126 NEW ZEALAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 127 KOREA ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 128 VIETNAM ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 129 THAILAND ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 130 PHILIPPINES ANTIBIOTICS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 131 INDIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 132 AUSTRALIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 133 CHINA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 134 INDONESIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 135 MALAYSIA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 136 NEW ZEALAND ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 137 KOREA ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 138 VIETNAM ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 139 THAILAND ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 140 PHILIPPINES ANTIBLOAT IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 141 INDIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 142 AUSTRALIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 143 CHINA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 144 INDONESIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 145 MALAYSIA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 146 NEW ZEALAND HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 147 KOREA HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 148 VIETNAM HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 149 THAILAND HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 150 PHILIPPINES HORMONAL IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 151 INDIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 152 AUSTRALIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 153 CHINA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 154 INDONESIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 155 MALAYSIA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 156 NEW ZEALAND SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 157 KOREA SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 158 VIETNAM SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 159 THAILAND SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 160 PHILIPPINES SUPPLEMENTS IN VETERINARY MEDICINES MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 161 INDIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 162 AUSTRALIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 163 CHINA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 164 INDONESIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 165 MALAYSIA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 166 NEW ZEALAND VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 167 KOREA VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 168 VIETNAM VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 169 THAILAND VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 170 PHILIPPINES VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 171 INDIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 172 AUSTRALIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 173 CHINA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 174 INDONESIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 175 MALAYSIA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 176 NEW ZEALAND FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 177 KOREA FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 178 VIETNAM FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 179 THAILAND FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 180 PHILIPPINES FOOD PRODUCTION IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 181 INDIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 182 AUSTRALIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 183 CHINA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 184 INDONESIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 185 MALAYSIA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 186 NEW ZEALAND COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 187 KOREA COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 188 VIETNAM COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 189 THAILAND COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 190 PHILIPPINES COMPANION ANIMALS IN VETERINARY MEDICINE MARKET, BY ANIMAL TYPE, 2021-2030 (USD MILLION)
TABLE 191 INDIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 192 AUSTRALIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 193 CHINA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 194 INDONESIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 195 MALAYSIA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 196 NEW ZEALAND VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 197 KOREA VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 198 VIETNAM VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 199 THAILAND VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 200 PHILIPPINES VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 201 INDIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 202 AUSTRALIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 203 CHINA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 204 INDONESIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 205 MALAYSIA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 206 NEW ZEALAND SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 207 KOREA SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 208 VIETNAM SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 209 THAILAND SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 210 PHILIPPINES SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 211 INDIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 212 AUSTRALIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 213 CHINA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 214 INDONESIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 215 MALAYSIA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 216 NEW ZEALAND LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 217 KOREA LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 218 VIETNAM LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 219 THAILAND LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 220 PHILIPPINES LIQUID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 221 INDIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 222 AUSTRALIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 223 CHINA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 224 INDONESIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 225 MALAYSIA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 226 NEW ZEALAND SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 227 KOREA SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 228 VIETNAM SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 229 THAILAND SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 230 PHILIPPINES SEMI-SOLID IN VETERINARY MEDICINE MARKET, BY DOSAGE, 2021-2030 (USD MILLION)
TABLE 231 INDIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 232 AUSTRALIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 233 CHINA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 234 INDONESIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 235 MALAYSIA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 236 NEW ZEALAND VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 237 KOREA VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 238 VIETNAM VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 239 THAILAND VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 240 PHILIPPINES VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 241 INDIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 242 AUSTRALIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 243 CHINA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 INDONESIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 245 MALAYSIA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 246 NEW ZEALAND VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 247 KOREA VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 VIETNAM VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 249 THAILAND VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 250 PHILIPPINES VETERINARY MEDICINE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 251 INDIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 252 AUSTRALIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 253 CHINA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 254 INDONESIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 255 MALAYSIA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 256 NEW ZEALAND VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 257 KOREA VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 258 VIETNAM VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 259 THAILAND VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 260 PHILIPPINES VETERINARY MEDICINE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 261 INDIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 262 AUSTRALIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 263 CHINA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 264 INDONESIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 265 MALAYSIA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 266 NEW ZEALAND VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 267 KOREA VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 268 VIETNAM VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 269 THAILAND VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 270 PHILIPPINES VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: SEGMENTATION
FIGURE 2 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DATA TRIANGULATION
FIGURE 3 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DROC ANALYSIS
FIGURE 4 INDIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 5 AUSTRALIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 6 CHINA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 7 INDONESIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 8 MALAYSIA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 9 NEW ZEALAND VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 10 KOREA VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 11 VIETNAM VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 12 THAILAND VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 13 PHILIPPINES VETERINARY MEDICINE MARKET: COUNTRY ANALYSIS
FIGURE 14 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 15 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 16 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: MARKET END USER COVERAGE GRID
FIGURE 17 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: DBMR MARKET POSITION GRID
FIGURE 18 INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET: SEGMENTATION
FIGURE 19 RISING PET OWNERSHIP AND HUMANIZATION OF PET IS EXPECTED TO DRIVE THE GROWTH OF THE INDIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 20 GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF AUSTRALIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 21 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY IS EXPECTED TO DRIVE THE GROWTH OF CHINA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 22 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE IS EXPECTED TO DRIVE THE GROWTH OF INDONESIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 23 RISING PET OWNERSHIP AND HUMANIZATION OF PET IS EXPECTED TO DRIVE THE GROWTH OF MALAYSIA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 24 GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF NEW ZEALAND VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 25 ADVANCEMENTS IN VETERINARY MEDICINE AND TECHNOLOGY IS EXPECTED TO DRIVE THE GROWTH OF KOREA VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 26 INCREASING GOVERNMENT INITIATIVES FOR ANIMAL HEALTH AND WELFARE IS EXPECTED TO DRIVE THE GROWTH OF VIETNAM VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 27 RISING PET OWNERSHIP AND HUMANIZATION OF PET ARE EXPECTED TO DRIVE THE GROWTH OF THAILAND VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 28 THE GROWING PREVALENCE OF ANIMAL DISEASES IS EXPECTED TO DRIVE THE GROWTH OF PHILIPPINES VETERINARY MEDICINE MARKET FROM 2023 TO 2030
FIGURE 29 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF INDIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 30 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF AUSTRALIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 31 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF CHINA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 32 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF INDONESIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 33 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF MALAYSIA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 34 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF NEW ZEALAND VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 35 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF KOREA VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 36 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF VIETNAM VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 37 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THAILAND VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 38 THE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF VIETNAM VETERINARY MEDICINE MARKET IN 2023 & 2030
FIGURE 39 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE INDONESIA, MALAYSIA, VIETNAM, THAILAND, PHILIPPINES, AUSTRALIA, NEW ZEALAND, CHINA, KOREA, AND INDIA VETERINARY MEDICINE MARKET
FIGURE 40 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 41 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 42 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 43 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 44 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 45 NEW ZEALAND VETERINARY MEDICINES MARKET: BY PRODUCT, 2022
FIGURE 46 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 47 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, 2022
FIGURE 48 THAILAND VETERINARY MEDICINES MARKET: BY PRODUCT, 2022
FIGURE 49 PHILIPPINES VETERINARY MEDICINES MARKET: BY PRODUCT, 2022
FIGURE 50 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 51 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 52 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 53 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 54 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 55 NEW ZEALAND VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 56 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 57 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 58 THAILAND VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 59 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 60 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 61 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 62 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 63 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 64 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 65 NEW ZEALAND VETERINARY MEDICINES MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 66 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 67 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 68 THAILAND VETERINARY MEDICINES MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 69 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 70 INDIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 71 AUSTRALIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 72 CHINA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 73 INDONESIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 74 MALAYSIA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 75 NEW ZEALAND VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 76 KOREA VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 77 VIETNAM VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 78 THAILAND VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 79 PHILIPPINES VETERINARY MEDICINE MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 80 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 81 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 82 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 83 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 84 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 85 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 86 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 87 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 88 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 89 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2022
FIGURE 90 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 91 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 92 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 93 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 94 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 95 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 96 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 97 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 98 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 99 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, 2023-2030 (USD MILLION)
FIGURE 100 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 101 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 102 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 103 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 104 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 105 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 106 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 107 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 108 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 109 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, CAGR (2023-2030)
FIGURE 110 INDIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 111 AUSTRALIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 112 CHINA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 113 INDONESIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 114 MALAYSIA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 115 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 116 KOREA VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 117 VIETNAM VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 118 THAILAND VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 119 PHILIPPINES VETERINARY MEDICINE MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 120 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 121 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 122 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 123 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 124 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 125 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 126 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 127 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 128 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 129 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, 2022
FIGURE 130 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 131 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 132 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 133 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 134 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 135 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 136 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 137 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 138 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 139 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, 2023-2030 (USD MILLION)
FIGURE 140 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 141 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 142 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 143 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 144 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 145 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 146 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 147 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 148 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 149 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, CAGR (2023-2030)
FIGURE 150 INDIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 151 AUSTRALIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 152 CHINA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 153 INDONESIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 154 MALAYSIA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 155 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 156 KOREA VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 157 VIETNAM VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 158 THAILAND VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 159 PHILIPPINES VETERINARY MEDICINE MARKET: BY DOSAGE, LIFELINE CURVE
FIGURE 160 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 161 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 162 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 163 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 164 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 165 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 166 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 167 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 168 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 169 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 170 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 171 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 172 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 173 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 174 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 175 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 176 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 177 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 178 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 179 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 180 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 181 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 182 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 183 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 184 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 185 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 186 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 187 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 188 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 189 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 190 INDIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 191 AUSTRALIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 192 CHINA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 193 INDONESIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 194 MALAYSIA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 195 NEW ZEALAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 196 KOREA VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 197 VIETNAM VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 198 THAILAND VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 199 PHILIPPINES VETERINARY MEDICINE MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 200 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 201 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 202 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 203 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 204 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 205 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 206 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 207 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 208 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 209 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, 2022
FIGURE 210 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 211 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 212 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 213 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 214 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 215 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 216 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 217 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 218 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 219 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 220 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 221 AUSTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 222 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 223 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 224 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 225 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 226 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 227 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 228 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 229 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 230 INDIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 231 ASUTRALIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 232 CHINA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 233 INDONESIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 234 MALAYSIA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 235 NEW ZEALAND VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 236 KOREA VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 237 VIETNAM VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 238 THAILAND VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 239 PHILIPPINES VETERINARY MEDICINE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 240 INDIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 241 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 242 CHINA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 243 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 244 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 245 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 246 KOREA VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 247 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 248 THAILAND VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 249 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, 2022
FIGURE 250 INDIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 251 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 252 CHINA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 253 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 254 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 255 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 256 KOREA VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 257 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 258 THAILAND VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 259 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 260 INDIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 261 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 262 CHINA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 263 INDONESIA IMMUNODIAGNOSTICS SMARKET: BY END USER, CAGR (2023-2030)
FIGURE 264 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 265 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 266 KOREA VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 267 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 268 THAILAND VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 269 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 270 INDIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 271 AUSTRALIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 272 CHINA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 273 INDONESIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 274 MALAYSIA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 275 NEW ZEALAND VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 276 KOREA VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 277 VIETNAM VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 278 THAILAND VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 279 PHILIPPINES VETERINARY MEDICINE MARKET: BY END USER, LIFELINE CURVE
FIGURE 280 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 281 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 282 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 283 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 284 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 285 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 286 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL ,2022
FIGURE 287 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 288 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 289 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 290 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 291 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 292 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 293 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 294 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 295 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 296 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 297 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 298 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 299 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 300 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 301 AUSTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 302 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 303 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 304 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 305 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 306 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 307 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 308 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 309 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 310 INDIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 311 ASUTRALIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 312 CHINA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 313 INDONESIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 314 MALAYSIA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 315 NEW ZEALAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 316 KOREA VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 317 VIETNAM VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 318 THAILAND VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 319 PHILIPPINES VETERINARY MEDICINE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 320 INDIA VETERINARY MARKET: COMPANY SHARE 2022 (%)
FIGURE 321 AUSTRALIA VETERINARY MARKET: COMPANY SHARE 2022 (%)
FIGURE 322 CHINA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 323 INDONESIA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 324 MALAYSIA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 325 NEW ZEALAND VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 326 KOREA VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 327 VIETNAM VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 328 THAILAND VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
FIGURE 329 PHILIPPINES VETERINARY MEDICINE MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
